Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Extracorporeal Membrane Oxygenation | 16 | 2021 | 5002 | 1.66 | Why? |
Heart Arrest | 3 | 2018 | 1239 | 0.72 | Why? |
Isoflurane | 1 | 2018 | 38 | 0.71 | Why? |
Mitral Valve Insufficiency | 2 | 2019 | 302 | 0.68 | Why? |
Cold Ischemia | 1 | 2016 | 37 | 0.67 | Why? |
Cardiopulmonary Resuscitation | 4 | 2018 | 1876 | 0.66 | Why? |
Fluid Therapy | 2 | 2018 | 628 | 0.65 | Why? |
Albumins | 1 | 2018 | 324 | 0.63 | Why? |
Myocardial Contraction | 1 | 2016 | 123 | 0.60 | Why? |
Hypothermia, Induced | 1 | 2018 | 176 | 0.60 | Why? |
Propofol | 1 | 2018 | 172 | 0.59 | Why? |
Shock, Cardiogenic | 2 | 2020 | 700 | 0.59 | Why? |
Myocardial Reperfusion Injury | 1 | 2016 | 129 | 0.58 | Why? |
Respiratory Distress Syndrome, Newborn | 1 | 2016 | 124 | 0.58 | Why? |
Hypnotics and Sedatives | 1 | 2018 | 624 | 0.47 | Why? |
Resuscitation | 1 | 2017 | 638 | 0.45 | Why? |
Ventricular Dysfunction, Left | 1 | 2016 | 993 | 0.36 | Why? |
Ventricular Function, Left | 1 | 2016 | 1555 | 0.34 | Why? |
Heart Transplantation | 1 | 2016 | 1293 | 0.31 | Why? |
Time Factors | 8 | 2021 | 31397 | 0.25 | Why? |
Treatment Outcome | 8 | 2021 | 51732 | 0.22 | Why? |
Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.22 | Why? |
Barotrauma | 1 | 2020 | 97 | 0.19 | Why? |
Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.18 | Why? |
Vascular Patency | 1 | 2018 | 96 | 0.17 | Why? |
Registries | 8 | 2021 | 12327 | 0.17 | Why? |
Assisted Circulation | 1 | 2017 | 30 | 0.17 | Why? |
Out-of-Hospital Cardiac Arrest | 2 | 2018 | 1047 | 0.17 | Why? |
Angina Pectoris | 1 | 2018 | 114 | 0.17 | Why? |
Stress, Mechanical | 1 | 2016 | 143 | 0.16 | Why? |
Magnetic Resonance Angiography | 1 | 2018 | 282 | 0.16 | Why? |
Multicenter Studies as Topic | 2 | 2021 | 2437 | 0.16 | Why? |
Coma | 1 | 2018 | 204 | 0.15 | Why? |
Biomechanical Phenomena | 1 | 2016 | 291 | 0.15 | Why? |
Cardiac Output | 1 | 2017 | 183 | 0.15 | Why? |
Transportation of Patients | 1 | 2021 | 494 | 0.15 | Why? |
Echocardiography, Three-Dimensional | 1 | 2016 | 135 | 0.15 | Why? |
Absorbable Implants | 1 | 2018 | 191 | 0.15 | Why? |
Mitral Valve | 1 | 2019 | 342 | 0.14 | Why? |
Lung | 2 | 2020 | 31049 | 0.14 | Why? |
Survival Analysis | 2 | 2018 | 7592 | 0.14 | Why? |
Mobile Health Units | 1 | 2021 | 741 | 0.13 | Why? |
Respiratory Therapy | 1 | 2021 | 918 | 0.13 | Why? |
Pulmonary Artery | 1 | 2020 | 803 | 0.13 | Why? |
Echocardiography, Transesophageal | 1 | 2017 | 447 | 0.13 | Why? |
Cerebral Hemorrhage | 1 | 2021 | 820 | 0.12 | Why? |
Germany | 4 | 2021 | 9196 | 0.12 | Why? |
Randomized Controlled Trials as Topic | 3 | 2021 | 10649 | 0.12 | Why? |
Retrospective Studies | 12 | 2021 | 105322 | 0.12 | Why? |
Hemodynamics | 2 | 2017 | 1562 | 0.11 | Why? |
Heart-Assist Devices | 1 | 2020 | 812 | 0.11 | Why? |
Aged | 15 | 2021 | 215776 | 0.10 | Why? |
Heart Valve Prosthesis Implantation | 1 | 2017 | 552 | 0.10 | Why? |
Computed Tomography Angiography | 1 | 2020 | 2153 | 0.10 | Why? |
Cytokines | 3 | 2021 | 15010 | 0.10 | Why? |
Delirium | 1 | 2020 | 1061 | 0.10 | Why? |
Humans | 28 | 2021 | 930598 | 0.10 | Why? |
Recovery of Function | 1 | 2020 | 2461 | 0.10 | Why? |
Double-Blind Method | 1 | 2020 | 5988 | 0.09 | Why? |
Critical Illness | 3 | 2021 | 17281 | 0.09 | Why? |
Ventilators, Mechanical | 1 | 2020 | 2193 | 0.09 | Why? |
Respiratory Insufficiency | 2 | 2020 | 7301 | 0.09 | Why? |
Middle Aged | 15 | 2021 | 270681 | 0.09 | Why? |
Respiration, Artificial | 3 | 2021 | 22116 | 0.08 | Why? |
Stroke Volume | 1 | 2016 | 2153 | 0.08 | Why? |
Male | 14 | 2021 | 367725 | 0.08 | Why? |
Female | 14 | 2021 | 380317 | 0.08 | Why? |
Interleukin-6 | 2 | 2021 | 7522 | 0.07 | Why? |
Prospective Studies | 3 | 2021 | 43301 | 0.07 | Why? |
Predictive Value of Tests | 2 | 2020 | 9537 | 0.07 | Why? |
Pneumonia, Viral | 4 | 2020 | 243684 | 0.07 | Why? |
ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
Dyspnea | 1 | 2018 | 3847 | 0.07 | Why? |
Adult | 10 | 2021 | 244371 | 0.07 | Why? |
Ultrasonography | 1 | 2020 | 4409 | 0.07 | Why? |
Patient Selection | 1 | 2018 | 4560 | 0.07 | Why? |
Consensus | 1 | 2018 | 6345 | 0.06 | Why? |
Critical Care | 3 | 2021 | 14081 | 0.06 | Why? |
Logistic Models | 1 | 2017 | 9089 | 0.06 | Why? |
Pandemics | 6 | 2021 | 389249 | 0.06 | Why? |
Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
Longitudinal Studies | 1 | 2016 | 9893 | 0.05 | Why? |
Hospitals | 1 | 2021 | 11793 | 0.05 | Why? |
Percutaneous Coronary Intervention | 1 | 2018 | 3646 | 0.05 | Why? |
Adsorption | 1 | 2021 | 261 | 0.05 | Why? |
Critical Care Outcomes | 1 | 2020 | 138 | 0.05 | Why? |
Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.05 | Why? |
Anticoagulants | 1 | 2021 | 9563 | 0.05 | Why? |
Risk Assessment | 2 | 2020 | 25439 | 0.05 | Why? |
Influenza, Human | 2 | 2020 | 10779 | 0.05 | Why? |
Endpoint Determination | 1 | 2021 | 344 | 0.05 | Why? |
Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
Severity of Illness Index | 3 | 2021 | 48226 | 0.04 | Why? |
Polyesters | 1 | 2018 | 94 | 0.04 | Why? |
Chi-Square Distribution | 1 | 2020 | 961 | 0.04 | Why? |
Tissue Scaffolds | 1 | 2018 | 174 | 0.04 | Why? |
Multimodal Imaging | 1 | 2020 | 534 | 0.04 | Why? |
Survival Rate | 2 | 2021 | 9206 | 0.04 | Why? |
Infant, Newborn | 1 | 2016 | 23105 | 0.03 | Why? |
Risk Factors | 3 | 2021 | 71621 | 0.03 | Why? |
Infant | 1 | 2016 | 30274 | 0.03 | Why? |
Single-Blind Method | 1 | 2017 | 1283 | 0.03 | Why? |
Imaging, Three-Dimensional | 1 | 2018 | 680 | 0.03 | Why? |
Aged, 80 and over | 3 | 2021 | 88759 | 0.03 | Why? |
Propensity Score | 1 | 2021 | 2690 | 0.03 | Why? |
Child, Preschool | 1 | 2016 | 36283 | 0.03 | Why? |
Intensive Care Units | 3 | 2021 | 29594 | 0.02 | Why? |
Young Adult | 2 | 2021 | 93724 | 0.02 | Why? |
Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
Child | 1 | 2016 | 70012 | 0.02 | Why? |
Health Services Needs and Demand | 1 | 2021 | 3419 | 0.02 | Why? |
Adolescent | 1 | 2016 | 86841 | 0.02 | Why? |
Referral and Consultation | 1 | 2021 | 4816 | 0.02 | Why? |
Research Design | 1 | 2021 | 5830 | 0.02 | Why? |
Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
Occupational Exposure | 1 | 2021 | 4742 | 0.02 | Why? |
Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 9706 | 0.01 | Why? |
Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
Personal Protective Equipment | 1 | 2021 | 15978 | 0.01 | Why? |
Wengenmayer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(125)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(160)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_